ArticleCardiovascular diabetology2026
Increased epicardial adipose tissue area and radiodensity in sarcopenic obesity.
Article in Cardiovascular diabetology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundSarcopenic obesity (SO) confers substantially greater cardiometabolic risk than either sarcopenia or obesity alone, but the tissue-level structural alterations underlying this risk remain unclear. Epicardial adipose tissue (EAT) characteristics, including both area and radiodensity, may provide clinically relevant insight into the cardiometabolic burden associated with this complex muscle-fat imbalance.
methodsWe conducted a cross-sectional study of 1678 adults undergoing health examinations. Participants were categorized into normal, sarcopenia, obesity, and SO phenotypes based on the European Society for Clinical Nutrition and Metabolism and the European Association for the Study of Obesity (ESPEN/EASO) conceptual framework. Body composition and grip strength were assessed according to the Asian Working Group for Sarcopenia (AWGS) 2025 criteria. EAT area (cm
resultsThe SO phenotype was identified in 45 individuals. Following multivariable adjustment, SO was independently associated with a larger EAT area (beta = 6.93 cm
conclusionsIn this cross-sectional study, SO was associated with larger EAT area and higher EAT radiodensity. These findings support the presence of a distinct EAT phenotype in SO and suggest that CT-derived EAT measures may be useful imaging markers that warrant prospective validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.